ClinicalTrials.gov
ClinicalTrials.gov Menu

Pressurized PPV 23GA Vitrectomy in Complicated Diabetic Tractional Retinal Detachment

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00404209
Recruitment Status : Unknown
Verified November 2007 by Asociación para Evitar la Ceguera en México.
Recruitment status was:  Recruiting
First Posted : November 28, 2006
Last Update Posted : December 3, 2007
Sponsor:
Information provided by:
Asociación para Evitar la Ceguera en México

Brief Summary:
To investigate the feasibility and advantages of using pressurized perfluorocarbon liquid (PCL) perfusion to remove vitreous during suction-cutting 23 GA vitrectomy using a dual, dynamic drive (3D)technology, in complicated retinal detachment surgeries.

Condition or disease Intervention/treatment Phase
Retinal Detachment Procedure: Vitrectomy Phase 3

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 10 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Pressurized Perfluorocarbon Perfused 23 GA Vitrectomy in Complicated Diabetic Retinal Detachment
Study Start Date : March 2007
Estimated Study Completion Date : February 2008

Resource links provided by the National Library of Medicine



Intervention Details:
  • Procedure: Vitrectomy
    pressurized 23GA vitrectomy with a 3D system


Primary Outcome Measures :
  1. Perfluorocarbon liquids consumption [ Time Frame: two months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Complicated retinal detachment with no more than 6months of evolution

Exclusion Criteria:

  • Retinal detachments of more than 6 months of evolution No light perception

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00404209


Contacts
Contact: Hugo Quiroz-Mercado, MD 5255 10841400 ext 1171 retinamex@yahoo.com

Locations
Mexico
Asociación para Evitar la Ceguera en México, Hospital "Luis Sánchez Bulnes" Recruiting
Mexico City, Mexico DF, Mexico, 04030
Contact: Hugo Quiroz-Mercado, MD    5255 10841400 ext 1171    retinamex@yahoo.com   
Sub-Investigator: Maria A Martinez-Castellanos, MD         
Sub-Investigator: Gerardo Garcia-Aguirre, MD         
Sub-Investigator: Orlando Ustariz-Gonzalez, MD         
Sub-Investigator: Jose L Guerrero-Naranjo, MD         
Sub-Investigator: Jans Fromow-Guerra, MD         
Sponsors and Collaborators
Asociación para Evitar la Ceguera en México
Investigators
Principal Investigator: Hugo Quiroz-Mercado, MD Asociación para Evitar la Ceguera en Mexico, Hospital "Luis Sanchez Bulnes"
Principal Investigator: Raul Velez-Montoya, MD Asociación para Evitar la Ceguera en México

Responsible Party: Hugo Quiroz-Mercado, Asociacion para evitar la ceguera en Mexico
ClinicalTrials.gov Identifier: NCT00404209     History of Changes
Other Study ID Numbers: APEC-008
First Posted: November 28, 2006    Key Record Dates
Last Update Posted: December 3, 2007
Last Verified: November 2007

Additional relevant MeSH terms:
Dissociative Disorders
Retinal Detachment
Mental Disorders
Retinal Diseases
Eye Diseases